MARATTO

article · Translational Oncology

A Novel Epigenetic Strategy to Concurrently Block Immune Checkpoints PD-1/PD-L1 and CD155/TIGIT in Hepatocellular Carcinoma

202423 citationsOpen accessModern Sciences and Arts University

In plain language

No abstract is available for this record, so no summary has been generated.

Research topics

  • Cancer Immunotherapy and Biomarkers
  • Immune cells in cancer
  • Epigenetics and DNA Methylation

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.1016/j.tranon.2024.101961

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.